ArticleExperimental and therapeutic medicine2019

Eltrombopag enables initiation and completion of pegylated interferon/ribavirin therapy in Japanese HCV-infected patients with chronic liver disease and thrombocytopenia.

Takumi Kawaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.